MAP2K7 and melanoma: Melanoma cells resistant to the cytotoxic effects of MEK inhibitors counteracted TGF-β signaling through overexpression of the E3 ubiquitin ligase SMURF2, which resulted in increased expression of the transcription factors PAX3 and MITF.